MedTrace Logo

Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

NCT01101074 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135469

Last updated 2011-10-12

No results posted yet for this study

Summary

This observational study will evaluate the safety and effectiveness following administration of adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine through both an ad hoc active monitoring system and a passive surveillance of hospitalization in a large cohort.

Conditions

  • Influenza A (H1N1)

Interventions

OTHER

This is non-intervention observational study

This is non-intervention observational study

Sponsors & Collaborators

  • Novartis Vaccines

    lead INDUSTRY

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-01-31
Completion
2010-09-30

Countries

  • Italy

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101074 on ClinicalTrials.gov